eli lilly share price: Lilly rides wave of weight-loss drug demand, working to expand capacity

Eli Lilly on Tuesday forecast 2024 profit above Wall Street estimates on soaring demand for Zepbound, its recently approved weight-loss drug, and said it would have new supply from expanded manufactur...